CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 15,718	$ 6,223
General and administrative	6,433	2,170
Total operating expenses	22,151	8,393
Loss from operations	(22,151)	(8,393)
Other income:
Interest and other income, net	480	13
Total other income, net	480	13
Net loss	$ (21,671)	$ (8,380)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.69)	$ (6.67)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.69)	$ (6.67)
Weighted-average common shares outstanding, basic (in shares)	31,246,916	1,256,487
Weighted-average common shares outstanding, diluted (in shares)	31,246,916	1,256,487
Other comprehensive loss:
Unrealized loss on marketable securities	$ (1,535)	$ 0
Total other comprehensive loss	(1,535)	0
Total comprehensive loss	$ (23,206)	$ (8,380)